Part 1. Introduction 1.1 Market Definition 1.2 Key Benefit 1.3 Market Segment Part 2. Methodology 2.1 Primary 2.2 Secondary Part 3. Executive Summary Part 4. Market Overview 4.1 Introduction 4.2 Market Size and Forecast 4.3 Market Dynamics 4.3.1 Drivers 4.3.2 Restraints 4.4 Impact of COVID-19 Pandemic on Global Economy 4.5 Porter's Five Forces Analysis 4.5.1 Bargaining Power of Suppliers 4.5.2 Bargaining Power of Consumers 4.5.3 Threat of New Entrants 4.5.4 Threat of Substitute Products and Services 4.5.5 Degree of Competition Part 5. Global Market for Aesthetic Medicine by Product 5.1 Market Overview 5.2 Invasive Procedures 5.2.1 Market Size and Forecast 5.3 Non-invasive Procedures 5.3.1 Market Size and Forecast Part 6. Global Market for Aesthetic Medicine by Application 6.1 Market Overview 6.2 Beauty Center 6.2.1 Market Size and Forecast 6.3 Clinic 6.3.1 Market Size and Forecast 6.4 Hospital 6.4.1 Market Size and Forecast 6.5 Medical Spa 6.5.1 Market Size and Forecast Part 7. Global Market for Aesthetic Medicine by Geography 7.1 Overview 7.1.1 Market Size and Forecast 7.2 North America 7.2.1 Market Size and Forecast 7.2.2 North America: Aesthetic Medicine Market by Country 7.2.2.1 United States 7.2.2.2 Canada 7.2.2.3 Mexico 7.3 Europe 7.3.1 Market Size and Forecast 7.3.2 Europe: Aesthetic Medicine Market by Country 7.3.2.1 Germany 7.3.2.2 France 7.3.2.3 United Kingdom 7.3.2.4 Italy 7.3.2.5 Rest of The Europe 7.4 Asia-Pacific 7.4.1 Market Size and Forecast 7.4.2 Asia-Pacific: Aesthetic Medicine Market by Country 7.4.2.1 China 7.4.2.2 India 7.4.2.3 Japan 7.4.2.4 South Korea 7.4.2.5 ASEAN Countries 7.5 Middle East and Africa (MEA) 7.5.1 Market Size and Forecast 7.5.2 MEA: Aesthetic Medicine Market by Country 7.5.2.1 Saudi Arabia 7.5.2.2 South Africa 7.5.2.3 Turkey 7.6 South America 7.6.1 Market Size and Forecast 7.6.2 South America: Aesthetic Medicine Market by Country 7.6.2.1 Brazil 7.6.2.2 Argentina 7.6.2.3 Rest of South America Part 8. Competitive Landscape 8.1 Market Share 8.2 Mergers & Acquisitions, Agreements, Collaborations and Partnerships Part 9. Key Competitor Profiles 9.1 AbbVie Inc. (AlLergan Plc) 9.2 Ipsen S.A. 9.3 Johnson & Johnson 9.4 Medy Tox Inc 9.5 Sientra, Inc. *LIST IS NOT EXHAUSTIVE Part 10. Patent Analysis 10.1 Patent Statistics 10.2 Regional Analysis 10.3 Trends Analysis DISCLAIMER ABOUT GEN CONSULTING COMPANY